Abstracts

1164 – Projecting Demographics and Causes of Death Among People With HIV in Western Europe to 2050

Background Antiretroviral therapy (ART) scale-up in Western Europe has reduced the incidence of AIDS, increased life expectancies, and led to an aging population of people with HIV (PWH). We aimed to predict cause-specific mortality patterns in Western Europe in the context of changes in demographics and ART use. Methods A deterministic, compartmental model was parameterised…

1100 – Differential Impact of Social Determinants of Health by Sex in HIV for COVID-19 Hospitalizations

Background Our study investigated sex differences in how individual-level social determinants of health (SDoH) affect COVID-19 related hospitalizations among people with HIV (PWH) and without HIV (PWoH) in the U.S.  Methods We analyzed the National COVID-19 Cohort Collaborative (N3C) data from January 2020 to November 2023 to assess how SDoH (healthcare access, economic stability, social…

1162 – Reducing HIV Diagnoses and Mortality Rate Further Increases Aging Resource Needs for PWH Into 2040

Background Increased survival has changed the age distribution of people with HIV in the United States (U.S.). Over 2010-2022, the fraction of people with diagnosed HIV (PWDH) aged > 50 years increased to 54%. Forecasts of future age distributions are needed to inform resource planning. Methods We used a life table model with age-specific mortality to predict future…

1081 – Refining Clinical Retention Metrics to Reflect the Realities of HIV Care in North America

Background “Retention” in care is a key health monitoring benchmark among people with HIV (PWH). However, not all retention metrics predict important downstream outcomes, particularly with decreasing frequency of clinical monitoring. We therefore assessed the association of multiple retention metrics with mortality in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Methods…